With the same focus, #SpecializedDiagnostics, Werfen and Omixon are the perfect match. The Omixon team is excited to join Werfen and contribute to #PoweringPatientCare.

Contact us: info@werfen.com | Visit Werfen.com

  • Products
  • About Us
  • Blog
  • Omixon Academy
  • Resources
  • Contact us
  • Search
  • Request HLA Assay
  • Request HLA Software
  • MyOmixon
Welcome to Omixon's blog! We're passionate scientists, software developers and business people, so we like to comment on new developments, our events, announcements or any other scientific topic we think is important. Your comments are welcome too, so connect with us on Social Media!

cancer

  1. Home ›
  2. Posts tagged "cancer"
  • News
  • Events

Webinar – HLA Genotype Shapes JAK2 V617F Driven Oncogenesis

21/09/2020
Join us for a webinar with Prof. Milena Ivanova MD (Molecular Biologist, Lab Co-Director at the Dept. of Clinical Immunology, University Hospital Aleksandrovska, Sofia, Bulgaria) and Libor Kolesár (Senior Field Applications Scientist & Assay Product Manager, Omixon).   HLA class I and class II alleles have been shown to...

 

Read more

Tagged alleles, cancer, genetics, hla, hla typing, immunoediting

Loss of Heterozygosity – “Cancer Mimicry”

27/06/2019
Article written by Vera Siffnerova (FAS, Omixon) In most Slavic languages, LOH stands for Summer Olympic Games (e. g. Letní Olympijské Hry in Czech), in HLA world, LOH is known as an abbreviation of an important disease marker – Loss of Heterozygosity – during which different types of cancer...

 

Read more

Tagged cancer, heterozygosity, hla, LOH, MHC, phenotypes

How Immunotherapy of Cancer May Create Novel Clinical Utilities for HLA Typing

15/12/2017
Written by Dr. Attila Bérces (Founder and Chairman, Omixon) The article was originally published in ASHI Quarterly Q3 2017   While the role of HLA has been demonstrated in over hundred diseases, its clinical utility and impact outside transplantation has been limited. Transplantation still dominates the demand for HLA...

 

Read more

Tagged ASHI, Attila Berces, cancer, hla, hla typing, immunotherapy

Human Leukocyte Antigen as a Critical Biomarker for the Adoption of Novel Immunotherapies of Cancer

15/06/2017
– Written by Attila Bérces (Founder and Chairman, Omixon) While the role of HLA has been demonstrated in over hundred diseases, its clinical utility and impact outside transplantation has been limited. Transplantation is still the dominant driver for the clinical HLA typing market. A new therapeutic paradigm in cancer...

 

Read more

Tagged biomarkers, cancer, hla, immunotherapy

Cancer Immunotherapy Proved to be Fertile Ground for Personalized Medicine

14/09/2016
Written by Dr. Attila Berces, Chairman at Omixon. Share the original article on LinkedIn here…   “We try to remember that medicine is for the patient. We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have...

 

Read more

Tagged cancer, immunotherapy, medicine
  • 1
  • 2
  • »

NanoTYPE Press Release

Sales and Price Information

If you have any sales related requests, please contact us!

Contact Us

BECOME OUR DISTRIBUTOR

Sign up by filling out the distributor application form!

Sign Up

Need Support?

Find all Omixon products or service related downloads here!

Downloads

Events

 

EVENTS 2023

SEE MORE »

Training and Field Support

A variety of training options are available!

Learn More

Quality Management System

Omixon activities covered by ISO 13485:2016 & EN ISO 13485:2016

 

 

Omixon Academy

Improve your knowledge!

Our Training Series provide ABHI accredited webinars, workshops, onsite trainings and online demo.

Read more

 

 

Contact Us

Just ask! Get answers!

Your questions and comments are important to us. We’ve got you covered.

Read more

 

 

Omixon Newsletter

Subscribe now!

By clicking 'Ok' I accept the
Privacy Policy

 

Sitemap

Products

  • NanoTYPE™
  • Holotype HLA™
  • HLA Twin™
  • HoloGRAFT™
  • Training and Field Support

 

Company

  • About
  • Board of Directors
  • Scientific Advisory Board
  • CSR Activities
  • Careers / Internships
  • MyOmixon
  • Cooperations and Sponsorships
  • Events

 

Omixon Academy

  • HLA Twin Videos
  • Lab Train Me Videos
  • Posters
  • Workshops
  • Symposiums
  • Webinars
  • Accreditation

 

Contact us

  • Distributors and Agents

Our Mailing Address:

Omixon Biocomputing Ltd.
H-1117 Budapest,
Kaposvár u. 14-18.,
Hungary, EU

US Branch Office:

Omixon Inc.
6 Liberty Square # 2823
Boston, MA 02109
United States

sales@omixon.com | www.omixon.com

support@omixon.com

 

2012-2022, Omixon Inc. All Rights Reserved.